Cure My Disease

Don't miss your cure!

 Log in / Sign up

New contact lens trial aims to stop worsening eyesight in children

NCT ID NCT05159765

Disease control Sponsor: Visioneering Technologies, Inc Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study tests whether NaturalVue multifocal contact lenses can slow the progression of myopia (nearsightedness) in children aged 7 to 12. Over three years, 144 kids will wear either standard single-vision lenses or the multifocal lenses. Researchers will measure changes in their prescription and eye length to see if the multifocal design helps control myopia.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
contact lenses
What this could lead to
If successful, this could provide a simple, non-invasive way to slow worsening nearsightedness in children, reducing their risk of serious eye problems later in life.
What could go wrong
This is a mid-stage trial with 144 participants, so results may not apply to everyone. The lenses are already approved for vision correction, but their ability to slow myopia progression is still being tested.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 144 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jan 2022

Expected to finish

Feb 2026

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

7 to 13 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Male or female, aged 7 to \<13 (inclusive) at the Screening/Baseline examination. 2. Meet the following refractive criteria determined by cycloplegic autorefraction at Screening/Baseline: * Spherical Equivalent Refractive Error (SERE): between -0.75 and -5.00 D inclusive. * Astigmatism: ≤ -0.75 D * Anisometropia: \< 1.000 Exclusion Criteria: 1. Has previously worn or currently wears rigid or gas permeable contact lenses, including orthokeratology lenses, 2. Appears to exhibit poor personal hygiene, that, in the Investigator's opinion, might prevent safe contact lens wear. 3. Is currently, or within 30 days prior to this study has been, an active participant in another clinical study. 4. Current or prior use of bifocals, progressive addition lenses, atropine, pirenzepine, multifocal or specialized contact lenses, or ANY other myopia control treatment. 5. The Investigator for any reason considers that it is not in the best interest of the subject to participate in the study, including if the child is not mature enough to independently handle and care for soft contact lenses.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Myopia are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

myopia refractive error

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Myopia

Contacts and locations

Locations

  • Bellaire Family Eye Care

    Bellaire, Texas, 77401, United States

  • Cooper Eye Care

    New York, New York, 10065, United States

  • Fig Garden Optometry

    Fresno, California, 93704, United States

  • Hong Kong Polytechnic University

    Tsim Sha Tsui, Hong Kong

  • Myopia Specialist Centre

    Singapore, Singapore

  • North Suburban Vision Consultants

    Deerfield, Illinois, 60015, United States

  • Toronto Eye Care

    Toronto, Ontario, M4W 1A5, Canada

  • University of Waterloo School of Optometry

    Waterloo, Ontario, N2L 3G1, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.